Wittliff, J. L. Prognostic Factors in the Management of Breast Carcinoma. Advance for Med. Lab. Prof., 1998.

Wittliff, J. L. and Raffelsberger, W. Mechanisms of Signal Transduction: Sex Hormones, Their Receptors and Clinical Utility. J. Clin. Ligand Assay, 18:211-235,1995.

Miseljic, S., Cavazos, A. S. and Wittliff, J. L. Influence of Menopausal Status on Expression of Epidermal Growth Factor Receptors, HER-2/neu Oncoprotein and Cathepsin D in Breast Cancer. J. Clin. Ligand Assay, 18:176-180, 1995.

Miseljic, S., Galandiuk, S., Myers, S. D. and Wittliff, J. L. Expression of Urokinase-Type Plasminogen Activator and Plasminogen Activator Inhibitor in Colon Disease. J. Clin. Lab. Anal., 9:413-417, 1995.

Shaheen, R. M., Miseljic, S., Doering, D. L. and Wittliff, J. L. Comparison of Cathepsin D Determinations in Human Carcinomas by Enzyme Immunoassay and Immunoradiometric Assay. J. Clin. Lab. Anal., 9:351-358, 1995.

Shaheen, R. M., Miseljic, S., Wiehle, R. D. and Wittliff, J. L. Relation Between Cathepsin D Expression and Other Prognostic Factors in Breast Carcinomas. Clin. Chem., 41:1585-1591, 1995.

Miseljic, S., Galandiuk, S., Yang, A.-R., Fiechter, J. and Wittliff, J. L. Markers for Malignant Transformation of the Colon. J. Clin. Ligand Assay, 18(2):135-140, 1995.

Miseljic, S., Yang, A-R, Cline, V. J. M. and Wittliff, J. L. Expression of Epidermal Growth Factor Receptors in Human Breast Cancer: Mass Versus Ligand Binding Capacity. The Breast J., 1:102-106, 1995.

Wittliff, J. L. Hormone and Growth Factor Receptors. In: W. L. Donegan and J. S. Spratt (ed.), Cancer of the Breast, Chapter 16, pp. 346-374, Philadelphia, PA: W. B. Saunders Co., 1995.

Galandiuk, S., Miseljic, S., Yang, A.-R., Early, M., McCoy, M. D. and Wittliff, J. L. Expression of Hormone Receptors, Cathepsin-D, and HER-2/neu Oncoprotein in Normal Colon and Colonic Disease, Arch. Surg., 128:637-642, 1993.